One on one interaction/email interaction_Mr. Sandeep Toshniwal, CEO, Eurolife Healthcare Pvt. Ltd

One on one interaction/email interaction_Mr. Sandeep Toshniwal, CEO, Eurolife Healthcare Pvt. Ltd

Eurolife Healthcare takes over European operations of TEVA for Intravenous Infusions

Eurolife to further invest €50 million for expansion of its operations into the European and US markets

Mumbai: Eurolife Healthcare Pvt. Ltd., one of the leading Indian specialty pharmaceutical, manufacturing and distribution company, announced the takeover of TEVA’s Intravenous Infusions plant / operations, located in Hungary, for an undisclosed amount. With this takeover, Eurolife has emerged as the first Indian Company in the Intravenous Infusions business to set up manufacturing operations abroad. The company had in 2017 taken over American MNC Baxter’s India operations and has strategic thrust on growth via takeovers and acquisitions worldwide.

Announcing the break-through, Mr. Sandeep Toshniwal, CEO, Eurolife Healthcare Pvt. Ltd. said,“Eurolife Healthcare will invest €50 million over the next 3 years to build one of the single largest IV plants in the world at this location. The takeover of TEVA’s Infusion plant, gives us a distinct competitive advantage and will help us emerge as the leading international player in the category. This acquisition will also help us tap and service our EU and USA markets for IVs in a better way.”

Mr. Toshniwal also added, “Eurolife is also adding massive capacities across its manufacturing plants in India to further increase its footprint in the Indian market along with exports.”

 About Eurolife Healthcare Pvt Ltd:     (https://eurolifehealthcare.com/)

Started in 2001, Mumbai-based Eurolife Healthcare Pvt. Ltd, is a specialty Pharmaceutical Company, It manufactures and distributes an exclusive portfolio of healthcare formulations, Intravenous Infusions, Ophthalmics, Sterilized water for Injections, Nebules, Tablets, Capsules, Ointment and Creams. In the year 2018, the brand acquired No.1 position in India for IV fluids.

Eurolife has the largest production capacity of Intravenous Infusions in India. After acquiring Baxter International FFS Division in 2017, Eurolife has made its hold even more strong in the domestic and worldwide markets. The company aims to provide benchmark quality – Large Volume Parenterals / Small Volume Parenterals for the consumers at most economical prices. The driving force was the need of leading pharmaceutical organisation manufacturing assured quality products in this field.

To cater domestic and global clients, Eurolife has Strategic manufacturing plants located in different geographies with Roorkee in North, Waluj in West andAlathur in South. Every year, approximately 12,000 hospitals and nursing homes are covered by the team of Eurolife Healthcare.